Compounds > 25-hydroxycholesterol
Page last updated: 2024-08-24

25-hydroxycholesterol and Breast Neoplasms

25-hydroxycholesterol has been researched along with Breast Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutchinson, SA; Lundanes, E; Roberg-Larsen, H; Solheim, S; Thorne, JL; Wilson, SR1
Angelone, T; Cerra, MC; De Francesco, EM; Lappano, R; Maggiolini, M; Picard, D; Recchia, AG1
Larsson, O; Zetterberg, A1
Larsson, O1

Other Studies

4 other study(ies) available for 25-hydroxycholesterol and Breast Neoplasms

ArticleYear
Fast liquid chromatography-mass spectrometry reveals side chain oxysterol heterogeneity in breast cancer tumour samples.
    The Journal of steroid biochemistry and molecular biology, 2019, Volume: 192

    Topics: Breast Neoplasms; Chromatography, Liquid; Female; Humans; Hydroxycholesterols; Oxysterols; Tandem Mass Spectrometry

2019
The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes.
    PloS one, 2011, Jan-31, Volume: 6, Issue:1

    Topics: Animals; Apoptosis; Breast Neoplasms; Cholesterol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxycholesterols; Hypoxia; Lipid Metabolism; Myocytes, Cardiac; Ovarian Neoplasms; Rats; Signal Transduction

2011
Existence of a commitment program for mitosis in early G1 in tumour cells.
    Cell proliferation, 1995, Volume: 28, Issue:1

    Topics: 3T3 Cells; Animals; Breast Neoplasms; Cell Cycle; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Cycloheximide; DNA, Neoplasm; Fibroblasts; G1 Phase; Glioma; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred BALB C; Mitosis; Neoplasms; Time Factors; Tumor Cells, Cultured

1995
Cell cycle-specific growth inhibition of human breast cancer cells induced by metabolic inhibitors.
    Glycobiology, 1993, Volume: 3, Issue:5

    Topics: Antimetabolites; Breast Neoplasms; Cell Cycle; Cell Division; DNA, Neoplasm; Female; Glycosylation; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lovastatin; Mevalonic Acid; Neoplasm Proteins; Tumor Cells, Cultured; Tunicamycin

1993